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Abstract 
Chronic stress affects nano to microscale structures of the brain cells/tissues due the suppression of 
neural growths and reconnections, hence the neuronal activities. This results in depression, memory 
loss and even the death of the brain cells. Our recently developed novel optical technique, partial wave 
spectroscopic (PWS) microscopy has nanoscale sensitivity, and hence, can detect nanoscale changes in 
brain tissues due to stress. In this study, we applied this technique to quantify the stress related 
structural changes in the corticosterone-treated mouse model of stress. Our results show that brains 
from corticosterone-treated mice showed higher nanoscale structural disorder in the hippocampal 
region as compared to the brain from normal (vehicle) mice. The increase in structural alteration 
correlates with the duration of the stress. We further quantified the relative changes and the spatial 
localization of these changes in this mouse model and found out that the maximum changes occurred 
nearly symmetrically in both regions of the hippocampus.  The mRNA for stress-related genes, BDNF 
and TrkB were also significantly reduced in the hippocampus of corticosterone-treated mice compared 
to that in control mice. These results indicate that chronic corticosterone treatment induces nanoscale 
structural alterations in mouse brain that corresponds to the changes in stress-related gene expression.  
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1. Introduction:  
Stress has become an inevitable part of modern life. The hormone cortisol is mainly responsible 
for stress in humans. There are mainly two types of stresses: acute and chronic. When we talk about 
stress, it does not always have negative effects on brain. Some stress is necessary for the active and 
cognitive performance and development. Research have shown that acute stress helps in the 
proliferation of neural stem cells into new nerve cells and these new nerve cells on maturation 
increases the mental performance. The release of protein named fibroblast growth factor 2 (FGF2) by 
astrocytes in brain from stress causes the proliferation of these new nerve cells. Cortisol released 
because of acute stress is a response of fight-or-flight mechanism and the level of cortisol returns to 
original without any long-lasting effects. On other hand, chronic stress increases the level of stress 
hormone cortisol and this suppresses the development of new neurons in hippocampus as well as 
shrinkage of neural network. Chronic stress can lead to different body problems ranging from simple 
depression, viral infection to cancer. Most of the health problems nowadays are somehow inter-
connected to stress [1,2,3]. Studies have shown that chronic stress is responsible for mental and 
physical disorder by altering the gene control [4]. 
Epinephrine, norepinephrine and cortisol are the main three stress hormones in humans. 
Epinephrine and norepinephrine are the flight and fight hormones mainly responsible for the 
immediate reactions we feel when stressed. These hormones make us more aware, awake and focused 
and help in fleeing away from the stressful condition. Cortisol is the stress hormone which helps in 
fluid balance and blood pressure in optimal level. However, excessive level of cortisol interferes with 
learning and memory, lowers the immune system, increase body weight, increase blood pressure, 
causes fluid imbalances, causes heart diseases, diabetes, etc. This stress hormone is also recognized as 
‘Public enemy #1’. [5, 6, 7]. Chronic stress has multiple effects on brain from forgetfulness to death of 
brain cells and many neurological disorders. The inter connection between the structural alteration of 
the brain cells/tissues and the effect of the stress hormone cortisol is not well known and requires a 
systematic study. 
The role of brain-derived neurotrophic factor (BDNF) is established in stress and affective 
disorders. It has also been showed that BDNF was protective to neurons in conditions of chemical 
stress [8]. Both acute and chronic stresses have been shown to decrease the BDNF in various animal 
models and are involved in developing depressive phenotypes. Tyrosine kinase-coupled receptor 
(TrkB) is the primary signal transduction receptor for BDNF. BDNF and TrkB expression have been 
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shown to decrease in depression patient hippocampus. The activation of the BDNF-TrkB pathway is 
important in the development and the growth of neurons. 
 In this study, we measured nanoscale structural alterations in brain using a mouse model of 
chronic corticosterone administration and the novel nanoscale optical imaging technique and gene 
expression analysis.   
 
 
2. Method:  
2.1. Corticosterone induced mice animal model and brain tissue collections: 
The use of mice for experimentation purpose was approved by the Institutional Animal Care and Use 
Committee (IACUC) of the University of Tennessee UT, Health Science Center, Memphis, TN, USA, 
in accordance with institutional and U.S. federal guidelines. Mice were randomly divided into two 
groups (n = 6 per group) and injected (s.c.) either vehicle (control) or corticosterone (25 mg/kg in 
sesame oil) daily at 9 -10 AM for 7 and 10 days. Animals had ad libitum access to diet and water. 
Animals were sacrificed two hours after the injection on seventh and tenth day and brain hippocampus 
were collected for mRNA expression analysis. The brains were sectioned using a microtome and 
attached to a slide and fixed by using formalin.  The thickness of each brain slice sample was 10 µm. 
The fixed slides were then used for partial wave spectroscopy (PWS) microscopy studies. 
 
2.2. Optical partial wave experiments: 
 
The instrumentation of the PWS system, developed at University of Memphis that provides finer focus, 
is shown in the Fig. 1. The  sample is illuminated by a broadband of white light obtained from Xenon 
Lamp (Thor Lab) using Kohler Illumination. Light is first passed into a broadband dielectric round 
mirror (diameter= 50mm, R>99%, thickness=12.7mm,Newport) and is projected towards a set of 
lenses (convex, f=50mm,Thorlabs) and apertures for collimation as shown in Fig 1.A  right angle 
prism (25mm,Newport) reflects the collimated light and allows it  to pass through a beam splitter to a 
low numerical aperture objective (NA=0.65, 40x ,Newport). The beam is then focused on the sample. 
The sample is kept on the electronic motorized stage (Zaber Tech, Canada). The stage provides precise 
resolutions of 100nm in z direction and 40nm in x-y plane so that the control on the accurate depth of 
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focus after reflection from the sample is obtained. The backscattered light from the sample is passed 
through the objective again and strikes into a liquid crystal tunable filter (LCTF) (Verispace, LLC). 
LCTF filters the signal according to the wavelength components at a resolution of 1nm within the 
visible range (450-700nm). A CCD camera detector coupled with the LCTF captures the filtered 
signal. 
 
 
 
 
 
 
 
 
 
 
 
The backscattered image of the sample is detected and stored by the CCD camera at every wavelength 
(λ) in the visible range (450-700nm)..  The backscattered light spectra at a visible wavelength range 
from 450 to 700nm are captured from each pixel of CCD. The backscattered light spectrum is then 
normalized by the spectrum of the incident light and filtered to remove spectral noise. This yields a 
data cube R (λ, x, y) (λ is the wavelength, x and y are the pixel coordinates), which is referred to as the 
fluctuating part of the reflection coefficient. PWS measures the spectral fluctuations in the 
backscattering spectra. PWS virtually divides a cell into a collection of back-scattered parallel 
channels, where each channel with a diffraction-limited transverse size, detects back-scattered waves 
propagating along quasi 1D trajectories within these channels, and quantifies the statistical properties 
of the nanoarchitecture of a cell by the analysis of the fluctuating part of the reflected intensity 
R(λ,x,y). The reflection intensity spectral fluctuations in R(λ,x,y) arise from the multiple interference of 
photons reflected from refractive index fluctuations within a scattering object, i.e., the cell. These 
spectral fluctuations, originated from the multiple scattering from the sample, are analyzed by means 
of a quasi 1D mesoscopic light transport theory. This enables the quantification of the statistical 
properties of the spatial refractive index variations at any length scale including those well below the 
diffraction limit. The statistical parameter obtained from the analysis is the disorder strength Ld = < 
Figure 1:  Experimental setup for the Partial Wave Spectroscopy system.  L1, L2, L3 lens; 
A1, A2: Apertures; BS: Beam Splitter; M: Mirror; O Objective; S: Sample; LCTF: Liquid 
crystal Tunable Filter; CCD: Charge coupled device camera.  
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Δn2 > lc, where <Δn
2
 > and lc are the variance and the spatial correlation length of the refractive index 
fluctuations [9]. The disorder strength quantifies the spatial variability of refractive index and thus, the 
local concentration of intracellular material. 
 Experiments were performed longitudinally on the slide containing the brain sections of the 
mice.  Thirteen sets of PWS images for each three different samples were taken for each brain slices on 
the slide.  The reflected back scattering spectra R(λ,x,y) were taken for the whole visible range (400-
700nm), and were analyzed using the mesoscopic scattering algorithm and the degree of the structural 
disorder, or disorder strengths were calculated [10]. The samples were mice brain tissue with vehicle 
(i.e., control),  seven-day old mice brain tissue treated with corticosterone and ten-day old mice brain 
tissue treated with corticosterone. The average of the disorder strengths for each brain sample and the 
standard error were calculated the following formula: 
Ld =  <Δn
2
>lc 
Quantitative RT-PCR 
Total RNA (1.5 μg) was used for generation of cDNAs using the ThermoScript RT-PCR 
system for first strand synthesis (Invitrogen). Quantitative PCR (qPCR) reactions were performed 
using cDNA mix (cDNA corresponding to 35 ng RNA) with 300 nmoles of primers in a final volume 
of 25 μl of 2x concentrated RT2 Real-Time SYBR Green/ROX master mix (Qiagen) in an Applied 
Biosystems 7300 Real-Time PCR instrument (Norwalk, CT, USA). The cycle parameters were: 50°C 
for 2 minutes, one denaturation step at 95°C for 10 minutes and 40 cycles of denaturation at 95°C for 
10 seconds followed by annealing and elongation at 60°C. Relative gene expression of each transcript 
was normalized to GAPDH using the ΔΔCt method. Sequences of primers used for qPCR are provided 
in Table 1. 
Table 1. 
Gene 5′-3′ Sequence 
TrkB  
Forward Primer CTGGGGCTTATGCCTGCTG 
Reverse Primer AGGCTCAGTACACCAAATCCTA 
BDNF  
Forward Primer TCATACTTCGGTTGCATGAAGG 
Reverse Primer AGACCTCTCGAACCTGCCC 
GAPDH  
Forward Primer CTGCACCACCAACTGCTTAG 
Reverse Primer GGGCCATCCACAGTCTTCT 
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3. Results: 
3.1. Partial wave optical experimental result of structural disorder in the stressed 
induced Brain tissue sections:  
 
 In Fig. 2, the PWS analysis of the different mice brain tissues slices are shown. It can be seen in 
the bar graphs that there is an increase in the nanoscale structural disorder strength parameter Ld in the 
corticosterone treated mice brain tissues relative to the mice brain tissues with vehicle (control). The 
increase correlates with the duration of corticosterone treatments. 
 
 
 
 
 
 
 
 
 
 
 
 
Corticosterone, a main glucocorticoid is responsible for stress in rodents [11]. PWS optical 
measurements show that the brain tissue structural disorder is increased in the corticosterone treated 
brain tissue relative to the control (vehicle). This confirms that there are structural alterations in the 
brain tissues after the injection of corticosterone. Stress is responsible for the nanoscale changes in the 
brain tissues slice samples. The percentage change in disorder relative to the control (vehicle) mice 
brain tissue was approx. 6% for seven-day corticosterone-treated mice brain tissue and approx. 17% 
for ten-day corticosterone-treated mice brain tissue. These results suggest that higher disorder strength 
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Figure 2:  Figure: Stress-induced structural changes in mice brain tissues due to chronic stress 
treated with vehicle, brain tissue treated with corticosterone for seven days and brain tissue 
treated with corticosterone for ten days. The change in the disorder strength was found to be 
nearly 6% for brain tissues treated with corticosterone for seven days and nearly 17% for brain 
tissues treated with corticosterone for ten days. (P-value  <0.05) 
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in brain tissue is associated with the stress and hence the higher nanostructural alterations. The 
nanostructural alterations were found to be profound in the hippocampal region. Future study is needed 
to explore whether the disorder strength continues to increase with stress or saturates at a certain level 
of stress. In the following we studied the locations in brain where the higher nano structural alterations 
are taking place. 
 
 
 
 
 
 
 
 
 
 
 
3.2. The region specific structural changes in the brain: 
 PWS experiment was performed over 10µm thick brain section slide. The percentage change in the 
disorder strength along the brain slice sample position are maker by levels as shown in Fig. 3.(a). The 
middle portion in the figure is the ventricle and the region on either side of the ventricle is 
hippocampus.  We plotted nano-structural changes in percentages along this shaded stripe shown in the 
Figure 3:  Change in structural disorder or disorder strength due to corticosterone induced chronic 
stress in mice brain. (a) Schematic outline of the mice brain sections with hippocampal region. The 
shaded area represents the area where the PWS experiment was performed.  (b) Plot of the percentage 
change in the structural disorder or disorder strength Ld  versus position along  the brain section (as 
shown in the shaded region). The two peaks in the graph represent the maximum changes occurring 
in the hippocampal regions which are symmetrical on either side of the ventricle.  
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figure.  It can be seen in the figure that the percentage change versus position graph Fig. 3(b) clearly 
indicates that changes in disorder strength Ld are more in the hippocampal region because of 
corticosterone induced stress. 
 
3.3. Effect of corticosterone on BDNF and TrkB expression. 
 BDNF and TrkB are well known to be stress-related genes.  We evaluated the expression of 
these genes in hippocampus by measuring mRNA levels.  Data show that mRNA for both BDNF (Fig. 
4(a) and TrkB (Fig. 4(b)) were significantly decreased in the hippocampus of corticosterone-treated 
mice compared to that in vehicle-treated mice at Day 7 and Day 10 in a duration-dependent manner.  
 
 
 
 
 
.  
 
 
 
 
 
5. Discussions and Conclusions  
In this paper, we have reported stress induced nanoscale structural changes in brain tissue of a 
mice model.  The PWS optical study of the brain indicated that corticosterone-treated mice brain 
tissues have more structural changes than the mice brain tissues with vehicle. Corticosterone-treated 
day-ten mice brain tissues have more nanoscale structural disorder strength  than corticosterone-treated 
day-seven brain tissues. The disorder strength increases with the increase in the duration of the 
Figure 4: Corticosterone treatment down regulate BDNF and TrkB gene expression in the 
hippocampus. Stress was induced with corticosterone (25 mg/kg in sesame oil) daily for 7 and 10 
days as described in methods. At the Day 7 and 10, qRT-PCR analysis performed in RNA from 
hippocampal tissue for BDNF (a) and TrkB (b). Values are mean ± SE (n = 4). Asterisksindicate 
the values that are significantly (p < 0.05) different from corresponding control values.  
 
(a) (b) 
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corticosterone treatment. The changes are profound in the hippocampal region. The reversibility or 
irreversibility of the changes with the increase in corticosterone and total duration of injection is yet to 
be systematically explored.   
The role of brain-derived neurotrophic factor (BDNF) has been implicated in stress and 
affective disorders. It has also been shown that BDNF is protective to neurons in conditions of 
chemical stress [12]. Both acute and chronic stresses have been shown to decrease  BDNF expression 
in various animal models and are involved in developing depressive phenotypes. Our present study 
shows reduced BDNF expression in mouse hippocampus by chronic corticosterone administration and 
a corresponding increase in nanoscale structural disorder. Tyrosine kinase-coupled receptor (TrkB) is 
the primary signal transduction receptor for BDNF. BDNF and TrkB expression have been shown to 
decrease in the hippocampus of depression patients. The activation of the BDNF-TrkB pathway is 
important in the development and the growth of neurons. Suppression of this pathway by 
corticosterone suggests a chronically elevated corticosterone in mediating the depressive behavior 
during chronic stress. 
In summary, our data show that elevated plasma levels of corticosterone suppress BDNF-TrkB 
protection pathway in the hippocampus, which is associated with a corresponding change in nanoscale 
structural disorder in the hippocampus. 
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